Oellerich M - Search Results

1

Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy.

Oellerich M, Schütz E, Beck J, Walson PD. Oellerich M, et al. Ther Drug Monit. 2019 Apr;41(2):115-120. doi: 10.1097/FTD.0000000000000566. Ther Drug Monit. 2019. PMID: 30883505 Review.

2

Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation.

Oellerich M, Schütz E, Kanzow P, Schmitz J, Beck J, Kollmar O, Streit F, Walson PD. Oellerich M, et al. Ther Drug Monit. 2014 Apr;36(2):136-40. doi: 10.1097/FTD.0000000000000044. Ther Drug Monit. 2014. PMID: 24452066

3

Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study.

Oellerich M, Shipkova M, Asendorf T, Walson PD, Schauerte V, Mettenmeyer N, Kabakchiev M, Hasche G, Gröne HJ, Friede T, Wieland E, Schwenger V, Schütz E, Beck J. Oellerich M, et al. Am J Transplant. 2019 Nov;19(11):3087-3099. doi: 10.1111/ajt.15416. Epub 2019 May 28. Am J Transplant. 2019. PMID: 31062511 Free PMC article.

4

Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.

Oellerich M, Sherwood K, Keown P, Schütz E, Beck J, Stegbauer J, Rump LC, Walson PD. Oellerich M, et al. Nat Rev Nephrol. 2021 Sep;17(9):591-603. doi: 10.1038/s41581-021-00428-0. Epub 2021 May 24. Nat Rev Nephrol. 2021. PMID: 34031575 Review.

5

Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury.

Oellerich M, Walson PD, Beck J, Schmitz J, Kollmar O, Schütz E. Oellerich M, et al. Ther Drug Monit. 2016 Apr;38 Suppl 1:S75-9. doi: 10.1097/FTD.0000000000000239. Ther Drug Monit. 2016. PMID: 26418703 Review.

6

Using circulating cell-free DNA to monitor personalized cancer therapy.

Oellerich M, Schütz E, Beck J, Kanzow P, Plowman PN, Weiss GJ, Walson PD. Oellerich M, et al. Crit Rev Clin Lab Sci. 2017 May;54(3):205-218. doi: 10.1080/10408363.2017.1299683. Epub 2017 Apr 10. Crit Rev Clin Lab Sci. 2017. PMID: 28393575 Review.

7

Cell-Free Plasma DNA for Disease Stratification and Prognosis in Head and Neck Cancer.

Schirmer MA, Beck J, Leu M, Oellerich M, Rave-Fränk M, Walson PD, Schütz E, Canis M. Schirmer MA, et al. Among authors: oellerich m. Clin Chem. 2018 Jun;64(6):959-970. doi: 10.1373/clinchem.2017.285668. Epub 2018 Apr 16. Clin Chem. 2018. PMID: 29661793

8

Plasma EGFR mutation testing in non-small cell lung cancer: A value proposition.

Oellerich M, Christenson RH, Beck J, Walson PD. Oellerich M, et al. Clin Chim Acta. 2019 Aug;495:481-486. doi: 10.1016/j.cca.2019.05.019. Epub 2019 May 21. Clin Chim Acta. 2019. PMID: 31125533 Free article. Review.

9

Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.

Oellerich M, Christenson RH, Beck J, Schütz E, Sherwood K, Price CP, Keown PA, Walson PD. Oellerich M, et al. J Appl Lab Med. 2020 Sep 1;5(5):993-1004. doi: 10.1093/jalm/jfaa062. J Appl Lab Med. 2020. PMID: 32447378

10

Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney Transplantation.

Schütz E, Asendorf T, Beck J, Schauerte V, Mettenmeyer N, Shipkova M, Wieland E, Kabakchiev M, Walson PD, Schwenger V, Oellerich M. Schütz E, et al. Among authors: oellerich m. Clin Chem. 2020 Oct 1;66(10):1290-1299. doi: 10.1093/clinchem/hvaa175. Clin Chem. 2020. PMID: 33001185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters